| 产品详情 |
| Edit |   |
|---|
| Product Name | SB 202190 |
|---|
| Description | MW: 331.34. Purity ≥98% by HPLC. Background: SB 202190 is a highly selective, potent, cell-permeable inhibitor of p38 MAP kinases, inhibiting p38alpha (SAPK2A, MAPK14) and p38beta (SAPK2B, MAPK11) with IC?? values of 50 and 100 nM, respectively. At higher concentrations (10 uM), SB 202190 displays negligible effects on several other kinases including other MAP kinases (ERKs, JNKs). |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [4-?[4-?(4-?fluorophenyl)-?5-?(4-?pyridinyl)-?1H-?imidazol-?2-?yl]-?phenol] |
|---|
| Gene, Accession, CAS # | CAS: 152121-30-7 |
|---|
| Catalog # | MBS843284 |
|---|
| Price | |
|---|
| Order / More Info | SB 202190 from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|